Interstitial lung disease

N. Nathan (Paris, France)

Source: International Congress 2019 – State of the art session: Paediatric respiratory diseases
Session: State of the art session: Paediatric respiratory diseases
Session type: Symposium
Number: 3748
Disease area: Paediatric lung diseases

WebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
N. Nathan (Paris, France). Interstitial lung disease. International Congress 2019 – State of the art session: Paediatric respiratory diseases

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Interstitial lung diseases
Source: ERS Course 2019 - Summer school of paediatric respiratory medicine 2019
Year: 2019

Interstitial lung diseases
Source: Eur Respir Monogr 2015; 70: 99-115
Year: 2015


Interstitial lung diseases
Source: HERMES Summer School 2014 - Educational material
Year: 2014

Interstitial lung diseases
Source: Annual Congress 2013 –Ceremony for ERS Research Award on Idiopathic Pulmonary Fibrosis (financially supported by InterMune) followed by Clinical Year in Review I
Year: 2013


Interstitial lung diseases
Source: Annual Congress 2012 - MS4 Interpreting high-resolution computed tomography scans: top tips
Year: 2012

Interstitial lung diseases
Source: ERS Course 2015
Year: 2015

Interstitial lung diseases
Source: ERS Course 2018 - Summer school of paediatric respiratory medicine
Year: 2018

Interstitial lung diseases
Source: Eur Respir Monogr 2014; 65: 79-87
Year: 2014


Interstitial lung disease; where do we stand without histopathology?
Source: Annual Congress 2013 –Diffuse parenchymal lung disease II
Year: 2013

Interstitial lung disease associated with polymyositis-dermatomyositis
Source: Eur Respir J 2005; 26: Suppl. 49, 31s
Year: 2005

Metabolic syndrome in interstitial lung diseases
Source: International Congress 2015 – IIPs: orphan
Year: 2015

Rituximab in severe, treatment-refractory interstitial lung disease
Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease
Year: 2013

Debate – Controversies in interstitial lung disease
Source: ERS webinar 2021

Access for REGISTERED non-members

Year: 2021

Biomarkers for interstitial lung disease
Source: International Congress 2016 – ME1 Biomarkers for interstitial lung disease
Year: 2016



"Cyclophosphamide for the treatment of inflammation driven fibrotic interstitial lung disease"
Source: International Congress 2014 – ILDs: connective tissue disease
Year: 2014

Nitrofurantoin-induced interstitial lung disease
Source: Annual Congress 2012 - Viral infections and rare respiratory infections
Year: 2012

Variation in mortality from interstitial lung disease by diagnosis
Source: International Congress 2015 – IIPs: orphan
Year: 2015